SAT0186 Developing predictors of global BILAG treatment response in patients with Lupus Nephritis: more lessons from the Aspreva Lupus Management Study group (ALMS) data

Research output: Contribution to journalAbstractpeer-review

Authors

  • MASTERPLANS

Colleges, School and Institutes

Details

Original languageEnglish
Pages (from-to)1034-1035
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume79
Issue numberSuppl 1
Publication statusPublished - 2 Jun 2020
EventEULAR annual meeting 2020 - Online
Duration: 3 Jun 20206 Jun 2020